Related references
Note: Only part of the references are listed.Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
Frank P. Hurst et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Intragraft Regulatory T Cells in Protocol Biopsies Retain Foxp3 Demethylation and Are Protective Biomarkers for Kidney Graft Outcome
O. Bestard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Alemtuzumab Induction in Renal Transplantation
Michael J. Hanaway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Immune Reconstitution Following Rabbit Antithymocyte Globulin
S. Gurkan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Identification of a B cell signature associated with renal transplant tolerance in humans
Kenneth A. Newell et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation
Florian Wolfgang Rudolf Vondran et al.
TRANSPLANT INTERNATIONAL (2010)
Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: An Analysis of United Network for Organ Sharing Registry Data
Junchao Cai et al.
TRANSPLANTATION (2010)
Outcomes in African-Americans vs. Caucasians Using Thymoglobulin or Interleukin-2 Receptor Inhibitor Induction: Analysis of USRDS Database
Rahul M. Jindal et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Memory T-Cell Predominance Following T-Cell Depletional Therapy Derives from Homeostatic Expansion of Naive T Cells
A. Sener et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
D. Bloom et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients
Christian Noel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
B-Cell-Depleting Induction Therapy and Acute Cellular Rejection
Menna R. Clatworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Alemtuzumab Versus Interleukin-2 Receptor Antibodies Induction in Living Donor Kidney Transplantation
Marcelo S. Sampaio et al.
TRANSPLANTATION (2009)
Rabbit Antithymocyte Globulin Is More Beneficial in Standard Kidney Than In Extended Donor Recipients
Karen L. Hardinger et al.
TRANSPLANTATION (2009)
Early Outcomes of Thymoglobulin and Basiliximab Induction in Kidney Transplantation: Application of Statistical Approaches to Reduce Bias in Observational Comparisons
Lisa M. Willoughby et al.
TRANSPLANTATION (2009)
A Randomized Trial of Alemtuzumab Versus Antithymocyte Globulin Induction in Renal and Pancreas Transplantation
Alan C. Farney et al.
TRANSPLANTATION (2009)
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation
J. A. Bluestone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro
Xingmin Feng et al.
BLOOD (2008)
Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts
Oriol Bestard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Long-term results of rabbit antithymocyte globulin and basiliximab induction
Daniel C. Brennan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A Prospective, Randomized, Double-Blinded Comparison of Thymoglobulin Versus Atgam for Induction Immunosuppressive Therapy: 10-Year Results
Karen L. Hardinger et al.
TRANSPLANTATION (2008)
A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up
Gaetano Ciancio et al.
CLINICAL TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation
V. Patlolla et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR study
H. Ekberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Rabbit antithymocyte globulin induction therapy in adult renal transplantation
Karen L. Hardinger
PHARMACOTHERAPY (2006)
Rabbit antithymocyte globulin versus basiliximab in renal transplantation
Daniel C. Brennan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A novel mechanism of action for anti-thymocyte globulin:: Induction of CD4+CD25+Foxp3+ regulatory T cells
Marta Lopez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance
S Louis et al.
TRANSPLANTATION (2006)
Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients
DP Funch et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results
DB Kaufman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring
G Ciancio et al.
TRANSPLANTATION (2005)
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation - Efficacy and safety at five years
CJE Watson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients
L Esposito et al.
TRANSPLANTATION PROCEEDINGS (2005)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Biological effects of induction immunosuppression
DA Hale
CURRENT OPINION IN IMMUNOLOGY (2004)
Five-year follow up of Thymoglobulin versus ATGAM induction in adult renal transplantation
KL Hardinger et al.
TRANSPLANTATION (2004)
A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients.
WC Goggins et al.
TRANSPLANTATION (2003)
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H)
AD Kirk et al.
TRANSPLANTATION (2003)
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients
B Charpentier et al.
TRANSPLANTATION (2003)
Immunotherapy: past, present and future
TA Waldmann
NATURE MEDICINE (2003)
Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation
G Ratzinger et al.
BLOOD (2003)
T-Cell depleting antibodies - New hope for induction of allograft tolerance in bone marrow transplantation?
DR Simpson
BIODRUGS (2003)
Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution
P Klangsinsirikul et al.
BLOOD (2002)
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression
G Mourad et al.
TRANSPLANTATION (2001)
Mechanisms involved in antithymocyte globulin immuno suppressive activity in a nonhuman primate model
X Préville et al.
TRANSPLANTATION (2001)
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy
RS Wildin et al.
NATURE GENETICS (2001)
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
ME Brunkow et al.
NATURE GENETICS (2001)
Immunologic and nonimmunologic factors - Different risks for cadaver and living donor transplantation
AJ Matas et al.
TRANSPLANTATION (2000)
Share Paper
